Therapeutic compositions (II)
AssigneeBTG International Limited
InventorRichard Lewis Veech
Life of this patent
Estimating the term…
Abstract
Method of producing a physiologically acceptable ketosis such as to treat a patient in need of therapy for one or more of Amylotrophic lateral sclerosis, Free Radical disease, Heart failure and Duchenne's muscular dystrophy by oral administration to the patient of a cyclic oligomer of formula (I) where n is an integer of 1 or more or a complex thereof with one or more cations or a salt thereof, wherein the physiologically acceptable ketosis is characterized by blood levels of (R)-3-hydroxybutyrate of from 0.5 to 20 mM.
Claims3
A method of producing a physiologically acceptable ketosis such as to treat a patient in need of therapy for one or more of Amylotrophic lateral sclerosis, and Duchenne's muscular dystrophy comprising oral administration to said patient of a ketogenic diet comprising a cyclic oligomer of formula (I)
- where n is an integer of 1 or more
- or a complex thereof with one or more cations or a salt thereof, wherein the physiologically acceptable ketosis is characterized by blood levels of (R)-3-hydroxybutyrate of from 0.5 to 20 mM.
Dependencies are inferred from the claim text.